» Articles » PMID: 24963489

Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Jun 26
PMID 24963489
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Glycyrrhizic acid (GA) is a triterpene glycoside found in the roots of licorice plants (Glycyrrhiza glabra). GA is the most important active ingredient in the licorice root, and possesses a wide range of pharmacological and biological activities. GA coupled with glycyrrhetinic acid and 18-beta-glycyrrhetic acid was developed in China or Japan as an anti-inflammatory, antiviral, and antiallergic drug for liver disease. This review summarizes the current biological activities of GA and its medical applications in liver diseases. The pharmacological actions of GA include inhibition of hepatic apoptosis and necrosis; anti-inflammatory and immune regulatory actions; antiviral effects; and antitumor effects. This paper will be a useful reference for physicians and biologists researching GA and will open the door to novel agents in drug discovery and development from Chinese herbs. With additional research, GA may be more widely used in the treatment of liver diseases or other conditions.

Citing Articles

A skin organoid-based infection platform identifies an inhibitor specific for HFMD.

Li J, Ma J, Cao R, Zhang Q, Li M, Wang W Nat Commun. 2025; 16(1):2513.

PMID: 40082449 PMC: 11906866. DOI: 10.1038/s41467-025-57610-2.


Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.

Cristani M, Citarella A, Carnamucio F, Micale N Biomolecules. 2024; 14(8).

PMID: 39199418 PMC: 11352298. DOI: 10.3390/biom14081031.


Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.

Tanabe K, Zahrieh D, Strand C, Hoshida Y, Flotte T, DellaZanna G Gastro Hep Adv. 2024; 3(3):426-439.

PMID: 39131140 PMC: 11307768. DOI: 10.1016/j.gastha.2024.01.009.


Natural Products from Herbal Medicine Self-Assemble into Advanced Bioactive Materials.

Guo X, Luo W, Wu L, Zhang L, Chen Y, Li T Adv Sci (Weinh). 2024; 11(35):e2403388.

PMID: 39033533 PMC: 11425287. DOI: 10.1002/advs.202403388.


Acute Lung Injury and the NLRP3 Inflammasome.

Gu W, Zeng Q, Wang X, Jasem H, Ma L J Inflamm Res. 2024; 17:3801-3813.

PMID: 38887753 PMC: 11182363. DOI: 10.2147/JIR.S464838.


References
1.
Tang B, Qiao H, Meng F, Sun X . Glycyrrhizin attenuates endotoxin- induced acute liver injury after partial hepatectomy in rats. Braz J Med Biol Res. 2007; 40(12):1637-46. DOI: 10.1590/s0100-879x2006005000173. View

2.
Makarenkova V, Bansal V, Matta B, Perez L, Ochoa J . CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol. 2006; 176(4):2085-94. DOI: 10.4049/jimmunol.176.4.2085. View

3.
Wan X, Luo M, Li X, He P . Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact. 2009; 181(1):15-9. DOI: 10.1016/j.cbi.2009.04.013. View

4.
Kang D, Sohn E, Lee H . Effects of glycyrrhizin on renal functions in association with the regulation of water channels. Am J Chin Med. 2003; 31(3):403-13. DOI: 10.1142/S0192415X03001089. View

5.
Ishida T, Mizushina Y, Yagi S, Irino Y, Nishiumi S, Miki I . Inhibitory effects of glycyrrhetinic Acid on DNA polymerase and inflammatory activities. Evid Based Complement Alternat Med. 2011; 2012:650514. PMC: 3138047. DOI: 10.1155/2012/650514. View